IgorJKoralnikMD

Director of the Global Neurology Program, Northwestern University

Dr. Koralnik is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
259 E Erie St
Chicago, IL 60611
Phone+1 312-695-7950

Fax+1 312-695-5747

Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1996 - 1997
Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1993 - 1996
University of Geneva Faculty of MedicineClass of 1987

PubMed

1439 citations
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Douglas B. Johnson, Justin M. Balko, Margaret L. Compton, Spyridon Chalkias, Joshua M. Gorham
The New England Journal of Medicine. 2016-11-02
52 citations
Analysis of 15 novel full-length BK virus sequences from three individuals: evidence of a high intra-strain genetic diversity.
Yiping Chen, Paul M. Sharp, Mary Fowkes, Olivier Kocher, Jeffrey T. Joseph
The Journal of General Virology. 2004-09-01
387 citations
Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers".
Edith L. Graham, Jeffrey R. Clark, Zachary S. Orban, Patrick H. Lim, April L. Szymanski
Annals of Clinical and Translational Neurology. 2021-05-01

Other

Approach to HIV-infected patients with central nervous system lesions
Koralnik IJ
http://www.uptodate.com/contents/approach-to-hiv-infected-patients-with-central-nervous-system-lesio
UpToDate, Wolters Kluwer Health - 2012-05-11
Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis
Koralnik IJ
http://www.uptodate.com/contents/progressive-multifocal-leukoencephalopathy-epidemiology-clinical-ma
UpToDate, Wolters Kluwer Health - 2013-01-09
Progressive multifocal leukoencephalopathy: Prognosis and treatment
Koralnik IJ
http://www.uptodate.com/contents/progressive-multifocal-leukoencephalopathy-prognosis-and-treatment
UpToDate, Wolters Kluwer Health - 2012-06-04

Nigerians Experiencing COVID-Debilitating Disorders – ExpertsOctober 27th, 2024
Nigerians Are Experiencing Neuro-Long COVID, Research FindsOctober 24th, 2024
In COVID-19 Patients, Neurological Symptoms May Last up to Three YearsAugust 16th, 2024
Join now to see all

Pathogenesis Of A JC Virus Variant In Pyramidal NeuronsNational Institute Of Neurological Disorders And Stroke2012
Translational Applications Of Progressive Multifocal Leukoencephalopathy StudiesNational Institute Of Neurological Disorders And Stroke2008–2012
Role Of Inflammation In Progressive Multifocal LeukoencephalopathyNational Institute Of Neurological Disorders And Stroke2008–2011
Cellular Immunity To JC Virus In Aids-Associated Progressive Multifocal LeukoenceNational Institute Of Neurological Disorders And Stroke2010
Cellular Immunity/Jc Virus/Aids/LeukoencephalopathyNational Institute Of Neurological Disorders And Stroke2005–2009
BK Virus ImmunityNational Center For Research Resources2007–2008
Inflammation In Progressive Multifocal LeukoencephalopathyNational Institute Of Neurological Disorders And Stroke2007
Granule Cell Neuron-Tropic JC Virus VariantNational Institute Of Neurological Disorders And Stroke2005–2006
Inflammation /Progressive Multifocal LeukoencephalopathyNational Institute Of Neurological Disorders And Stroke2004–2006
Aids-Assoc Progressive Multifocal LeukoencephalopathyNational Institute Of Neurological Disorders And Stroke2003–2004
Cellular Immunity To JC Virus In AIDS Associated PMLNational Institute Of Neurological Disorders And Stroke2001–2004
Immunopathogenesis Of PML In AIDSNational Institute Of Neurological Disorders And Stroke1997–2001